Cel Sci Corporation (CVM)

[Fosco1]

Hi Static

Another interesting study, around 3000 patients in 50 years
To be able to use as benchmark to CVM study, the first criteria to consider would be, in my opinion, the cancer stage, the second the dates : the sooner the better as they introduced more systematic S-CRT
So the interesting table is table 3.
Stage shall be "regional"
So here's how it went :

1960-1969 (%) 1970-1979 (%) 1980-1989 (%) 1990-1999 (%) 2000-2009 (%)

Regional 28.9 32.6 27.8 38.5 31.2


As you can notice soc is disastrous, never above 40% at Y5, most time around 30% and best years were 90/99 with 38.5

Well, while SOC OS might have improved in the 2011/2016 period, it is still probably as bad as possible and below 50%. This kind of bad prognosis should balance countries were OS is better in our study.

Room for optimism for Cel SCI PIII